时间：2020-07-22 08:16:40人气：8692来源： 迪拜新闻网
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
China advances local hybrid rice seed production overseas
(5990)人喜欢2026-10-18
Embodied AI events to highlight 2026 China Robot Competition in Hangzhou
(6008)人喜欢2026-10-13
China-Laos Railway handles over 80 million passenger trips since opening
(5269)人喜欢2026-10-10
'Meet China' film program brings Chinese cinema, cultural exchanges to Paris
(6022)人喜欢2026-10-05
Two giant pandas set off for 10-year stay at Zoo Atlanta in the U.S.
(6027)人喜欢2026-09-27
Dual holidays plus Canton Fair to drive passenger boom at Guangzhou Baiyun Airport
(6028)人喜欢2026-09-24
China Robot Summit sets standards and global roadmap for embodied AI
(6042)人喜欢2026-09-20
Inaugural Mudanjiang-Moscow freight train service launched
(6049)人喜欢2026-09-16